AGT and COVID-19: Additionally, the expression of the angiotensin-converting enzyme 2 (ACE2, which hydrolyses angiotensin II to angiotensin (1-7) and counteracts the ACE effects in the vascular system) was decreased in post-COVID-19 patients, compared with the COVID-19-free population [82].